{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T14:06:50Z","timestamp":1776002810080,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-05640-2","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T01:43:53Z","timestamp":1746495833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnosis and risk stratification of PI-RADS v2.1 category 3\u20135 lesions using amide proton transfer imaging"],"prefix":"10.1007","volume":"43","author":[{"given":"Hongkun","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weishu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoubin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"issue":"5","key":"5640_CR1","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H et al (2022) Cancer statistics in China and united States, 2022: profiles, trends, and determinants. Chin Med J (Engl) 135(5):584\u2013590. https:\/\/doi.org\/10.1097\/CM9.0000000000002108PMID: 35143424; PMCID: PMC8920425","journal-title":"Chin Med J (Engl)"},{"key":"5640_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ejca.2021.07.039","volume":"157","author":"T Dyba","year":"2021","unstructured":"Dyba T, Randi G, Bray F et al (2021) The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer 157:308\u2013347. https:\/\/doi.org\/10.1016\/j.ejca.2021.07.039Epub 2021 Sep 21. PMID: 34560371; PMCID: PMC8568058","journal-title":"Eur J Cancer"},{"issue":"2","key":"5640_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K et al (2023) 2022 Update on prostate Cancer epidemiology and risk Factors-A systematic review. Eur Urol 84(2):191\u2013206. https:\/\/doi.org\/10.1016\/j.eururo.2023.04.021Epub 2023 May 16. PMID: 37202314; PMCID: PMC10851915","journal-title":"Eur Urol"},{"key":"5640_CR4","doi-asserted-by":"publisher","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA, Grading Committee (2016) The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol. 40(2):244\u201352. https:\/\/doi.org\/10.1097\/PAS.0000000000000530. PMID: 26492179","DOI":"10.1097\/PAS.0000000000000530"},{"issue":"8","key":"5640_CR5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1080\/14737159.2020.1785288","volume":"20","author":"S Br\u00f6nimann","year":"2020","unstructured":"Br\u00f6nimann S, Pradere B, Karakiewicz P, Abufaraj M, Briganti A, Shariat SF (2020) An overview of current and emerging diagnostic, staging and prognostic markers for prostate cancer. Expert Rev Mol Diagn 20(8):841\u2013850 Epub 2020 Jun 25. PMID: 32552088","journal-title":"Expert Rev Mol Diagn"},{"issue":"2","key":"5640_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1148\/radiol.2021204112","volume":"300","author":"D Deniffel","year":"2021","unstructured":"Deniffel D, Healy GM, Dong X et al (2021) Avoiding unnecessary biopsy: MRI-based risk models versus a PI-RADS and PSA density strategy for clinically significant prostate Cancer. Radiology 300(2):369\u2013379. https:\/\/doi.org\/10.1148\/radiol.2021204112Epub 2021 May 25. PMID: 34032510","journal-title":"Radiology"},{"issue":"4","key":"5640_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1053\/j.sult.2020.04.003","volume":"41","author":"CV Stempel","year":"2020","unstructured":"Stempel CV, Dickinson L, Pends\u00e9 D (2020) MRI in the management of prostate Cancer. Semin Ultrasound CT MR 41(4):366\u2013372. https:\/\/doi.org\/10.1053\/j.sult.2020.04.003Epub 2020 May 7. PMID: 32620227","journal-title":"Semin Ultrasound CT MR"},{"issue":"11","key":"5640_CR8","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.crad.2019.05.019","volume":"74","author":"T Barrett","year":"2019","unstructured":"Barrett T, Rajesh A, Rosenkrantz AB, Choyke PL, Turkbey B (2019) PI-RADS version 2.1: one small step for prostate MRI. Clin Radiol 74(11):841\u2013852. https:\/\/doi.org\/10.1016\/j.crad.2019.05.019Epub 2019 Jun 22. PMID: 31239107","journal-title":"Clin Radiol"},{"key":"5640_CR9","doi-asserted-by":"publisher","unstructured":"Lo GC, Margolis DJA (2020) Prostate MRI with PI-RADS v2.1: initial detection and active surveillance. Abdom Radiol (NY). 45(7):2133\u20132142. https:\/\/doi.org\/10.1007\/s00261-019-02346-z. PMID: 31797025","DOI":"10.1007\/s00261-019-02346-z"},{"issue":"4","key":"5640_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10334-022-01019-1","volume":"35","author":"A O\u2019Shea","year":"2022","unstructured":"O\u2019Shea A, Harisinghani M (2022) PI-RADS: multiparametric MRI in prostate cancer. MAGMA 35(4):523\u2013532. https:\/\/doi.org\/10.1007\/s10334-022-01019-1Epub 2022 May 21. PMID: 35596009","journal-title":"MAGMA"},{"issue":"3","key":"5640_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.eururo.2020.03.048","volume":"78","author":"NJ Sathianathen","year":"2020","unstructured":"Sathianathen NJ, Omer A, Harriss E et al (2020) Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate Cancer in the prostate imaging reporting and data system era: A systematic review and Meta-analysis. Eur Urol 78(3):402\u2013414 Epub 2020 May 20. PMID: 32444265","journal-title":"Eur Urol"},{"issue":"5","key":"5640_CR12","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/jmri.27692","volume":"54","author":"SJ Hectors","year":"2021","unstructured":"Hectors SJ, Chen C, Chen J et al (2021) Magnetic resonance imaging Radiomics-Based machine learning prediction of clinically significant prostate Cancer in equivocal PI-RADS 3 lesions. J Magn Reson Imaging 54(5):1466\u20131473. https:\/\/doi.org\/10.1002\/jmri.27692Epub 2021 May 10. PMID: 33970516","journal-title":"J Magn Reson Imaging"},{"issue":"1118","key":"5640_CR13","doi-asserted-by":"publisher","first-page":"20191050","DOI":"10.1259\/bjr.20191050","volume":"94","author":"A Wadera","year":"2021","unstructured":"Wadera A, Alabousi M, Pozdnyakov A et al (2021) Impact of PI-RADS category 3 lesions on the diagnostic accuracy of MRI for detecting prostate cancer and the prevalence of prostate cancer within each PI-RADS category: A systematic review and meta-analysis. Br J Radiol 94(1118):20191050. https:\/\/doi.org\/10.1259\/bjr.20191050Epub 2020 Oct 22. PMID: 33002371; PMCID: PMC7934301","journal-title":"Br J Radiol"},{"issue":"5","key":"5640_CR14","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.euo.2019.08.015","volume":"3","author":"UG Falagario","year":"2020","unstructured":"Falagario UG, Martini A, Wajswol E et al (2020) Avoiding unnecessary magnetic resonance imaging (MRI) and biopsies: negative and positive predictive value of MRI according to Prostate-specific antigen density, 4Kscore and risk calculators. Eur Urol Oncol 3(5):700\u2013704 Epub 2019 Sep 20. PMID: 31548130","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"5640_CR15","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1002\/cam4.5100","volume":"12","author":"C Hu","year":"2023","unstructured":"Hu C, Sun J, Xu Z et al (2023) Development and external validation of a novel nomogram to predict prostate cancer in biopsy-na\u00efve patients with PSA\u2009<\u200910 Ng\/ml and PI-RADS v2.1\u2009=\u20093 lesions. Cancer Med 12(3):2560\u20132571. https:\/\/doi.org\/10.1002\/cam4.5100Epub 2022 Aug 3. PMID: 35920264; PMCID: PMC9939143","journal-title":"Cancer Med"},{"issue":"10","key":"5640_CR16","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.1007\/s00330-020-06884-9","volume":"30","author":"N Meng","year":"2020","unstructured":"Meng N, Wang X, Sun J et al (2020) Application of the amide proton transfer-weighted imaging and diffusion kurtosis imaging in the study of cervical cancer. Eur Radiol 30(10):5758\u20135767. https:\/\/doi.org\/10.1007\/s00330-020-06884-9Epub 2020 May 18. PMID: 32424593","journal-title":"Eur Radiol"},{"key":"5640_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13050914","author":"H Koike","year":"2023","unstructured":"Koike H, Morikawa M, Ishimaru H, Ideguchi R, Uetani M, Miyoshi M (2023) Diagnostics (Basel) 13(5):914. https:\/\/doi.org\/10.3390\/diagnostics13050914PMID: 36900058; PMCID: PMC10000843 Amide Proton Transfer-Chemical Exchange Saturation Transfer Imaging of Intracranial Brain Tumors and Tumor-like Lesions: Our Experience and a Review"},{"issue":"7","key":"5640_CR18","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1158\/0008-5472.CAN-18-2168","volume":"79","author":"KJ Ray","year":"2019","unstructured":"Ray KJ, Simard MA, Larkin JR et al (2019) Umor pH and protein concentration contribute to the signal of amide proton transfer magnetic resonance imaging. Cancer Res 79(7):1343\u20131352. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2168Epub 2019 Jan 24. PMID: 30679178; PMCID: PMC6462213","journal-title":"Cancer Res"},{"issue":"9","key":"5640_CR19","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.3174\/ajnr.A5301","volume":"38","author":"C Su","year":"2017","unstructured":"Su C, Liu C, Zhao L et al (2017) Amide proton transfer imaging allows detection of glioma grades and tumor proliferation: comparison with Ki-67 expression and proton MR spectroscopy imaging. AJNR Am J Neuroradiol 38(9):1702\u20131709. https:\/\/doi.org\/10.3174\/ajnr.A5301Epub 2017 Jul 20. PMID: 28729292; PMCID: PMC7963688","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"5640_CR20","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/jmri.28204","volume":"56","author":"Z Guo","year":"2022","unstructured":"Guo Z, Qin X, Mu R et al (2022) Amide proton transfer could provide more accurate lesion characterization in the transition zone of the prostate. J Magn Reson Imaging 56(5):1311\u20131319. https:\/\/doi.org\/10.1002\/jmri.28204 Epub 2022 Apr 16. PMID: 35429190","journal-title":"J Magn Reson Imaging"},{"key":"5640_CR21","doi-asserted-by":"publisher","unstructured":"Kido A, Tamada T, Ueda Y, Takeuchi M, Kanki A, Yamamoto A Comparison between amide proton transfer magnetic resonance imaging using 3-Dimensional acquisition and Diffusion-Weighted imaging for characterization of prostate cancer: A preliminary study. J Comput Assist Tomogr 2023 Mar-Apr 01;47(2):178\u2013185. https:\/\/doi.org\/10.1097\/RCT.0000000000001398. Epub 2022 Dec 13. PMID: 36729617.","DOI":"10.1097\/RCT.0000000000001398"},{"key":"5640_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mri.2022.11.004","volume":"96","author":"W Hu","year":"2023","unstructured":"Hu W, Chen L, Lin L, Wang J, Wang N, Liu A (2023) Three-dimensional amide proton transfer-weighted and intravoxel incoherent motion imaging for predicting bone metastasis in patients with prostate cancer: A pilot study. Magn Reson Imaging 96:8\u201316 Epub 2022 Nov 12. PMID: 36375760","journal-title":"Magn Reson Imaging"},{"issue":"2","key":"5640_CR23","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/mrm.29241","volume":"88","author":"J Zhou","year":"2022","unstructured":"Zhou J, Zaiss M, Knutsson L et al (2022) Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: application to brain tumors. Magn Reson Med 88(2):546\u2013574. https:\/\/doi.org\/10.1002\/mrm.29241Epub 2022 Apr 22. PMID: 35452155; PMCID: PMC9321891","journal-title":"Magn Reson Med"},{"issue":"21","key":"5640_CR24","doi-asserted-by":"publisher","first-page":"11559","DOI":"10.3390\/ijms222111559","volume":"22","author":"T Gao","year":"2021","unstructured":"Gao T, Zou C, Li Y, Jiang Z, Tang X, Song X (2021) A brief history and future prospects of CEST MRI in clinical Non-Brain tumor imaging. Int J Mol Sci 22(21):11559. https:\/\/doi.org\/10.3390\/ijms222111559PMID: 34768990; PMCID: PMC8584005","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5640_CR25","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/jmri.22480","volume":"33","author":"G Jia","year":"2011","unstructured":"Jia G, Abaza R, Williams JD et al (2011) Amide proton transfer MR imaging of prostate cancer: a preliminary study. J Magn Reson Imaging 33(3):647\u2013654. https:\/\/doi.org\/10.1002\/jmri.22480PMID: 21563248; PMCID: PMC4287206","journal-title":"J Magn Reson Imaging"},{"key":"5640_CR26","doi-asserted-by":"publisher","first-page":"640906","DOI":"10.3389\/fonc.2021.640906","volume":"11","author":"H Yin","year":"2021","unstructured":"Yin H, Wang D, Yan R et al (2021) Comparison of diffusion kurtosis imaging and amide proton transfer imaging in the diagnosis and risk assessment of prostate Cancer. Front Oncol 11:640906. https:\/\/doi.org\/10.3389\/fonc.2021.640906PMID: 33937041; PMCID: PMC8082407","journal-title":"Front Oncol"},{"issue":"1","key":"5640_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40644-022-00515-w","volume":"23","author":"L Yang","year":"2023","unstructured":"Yang L, Wang L, Tan Y et al (2023) Amide proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study. Cancer Imaging 23(1):3. https:\/\/doi.org\/10.1186\/s40644-022-00515-wPMID: 36611191; PMCID: PMC9826590","journal-title":"Cancer Imaging"},{"key":"5640_CR28","doi-asserted-by":"publisher","first-page":"562049","DOI":"10.3389\/fonc.2020.562049","volume":"10","author":"B Wu","year":"2020","unstructured":"Wu B, Jia F, Li X, Li L, Wang K, Han D (2020) Comparative study of amide proton transfer imaging and intravoxel incoherent motion imaging for predicting histologic grade of hepatocellular carcinoma. Front Oncol 10:562049. https:\/\/doi.org\/10.3389\/fonc.2020.562049PMID: 33194630; PMCID: PMC7659984","journal-title":"Front Oncol"},{"key":"5640_CR29","doi-asserted-by":"publisher","unstructured":"Wang XZ, Wang B, Gao ZQ et al (2009) Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation. J Magn Reson Imaging. 29(6):1360\u20136. https:\/\/doi.org\/10.1002\/jmri.21797. PMID: 19472393","DOI":"10.1002\/jmri.21797"},{"issue":"12","key":"5640_CR30","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1109\/TMI.2014.2336883","volume":"33","author":"K Nguyen","year":"2014","unstructured":"Nguyen K, Sarkar A, Jain AK (2014) Prostate cancer grading: use of graph cut and Spatial arrangement of nuclei. IEEE Trans Med Imaging 33(12):2254\u20132270. https:\/\/doi.org\/10.1109\/TMI.2014.2336883Epub 2014 Jul 10. PMID: 25029379","journal-title":"IEEE Trans Med Imaging"},{"issue":"5","key":"5640_CR31","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1177\/1971400916665382","volume":"29","author":"L El-Serougy","year":"2016","unstructured":"El-Serougy L, Abdel Razek AA, Ezzat A, Eldawoody H, El-Morsy A (2016) Assessment of diffusion tensor imaging metrics in differentiating low-grade from high-grade gliomas. Neuroradiol J 29(5):400\u2013407. https:\/\/doi.org\/10.1177\/1971400916665382Epub 2016 Aug 25. PMID: 27562582; PMCID: PMC5033100","journal-title":"Neuroradiol J"},{"issue":"4","key":"5640_CR32","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10334-016-0537-4","volume":"29","author":"Y Takayama","year":"2016","unstructured":"Takayama Y, Nishie A, Sugimoto M et al (2016) Amide proton transfer (APT) magnetic resonance imaging of prostate cancer: comparison with Gleason scores. MAGMA 29(4):671\u2013679. https:\/\/doi.org\/10.1007\/s10334-016-0537-4Epub 2016 Mar 10. PMID: 26965511","journal-title":"MAGMA"},{"issue":"3","key":"5640_CR33","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/neuonc\/not158","volume":"16","author":"O Togao","year":"2014","unstructured":"Togao O, Yoshiura T, Keupp J et al (2014) Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. Neuro Oncol 16(3):441\u2013448. https:\/\/doi.org\/10.1093\/neuonc\/not158Epub 2013 Dec 4. PMID: 24305718; PMCID: PMC3922507","journal-title":"Neuro Oncol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05640-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05640-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05640-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:50:36Z","timestamp":1767966636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05640-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5640"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05640-2","relation":{"references":[{"id-type":"doi","id":"10.3390\/diagnostics13050914","asserted-by":"subject"}],"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4845281\/v1","asserted-by":"object"}]},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"2 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"273"}}